Pfizer has reportedly made overtures offering to buy pharma giant AstraZeneca for $120 billions, the first mega matchup in pharma land in years.
Pfizer acquired Warner-Lambert in 2000 for $90 billions, Pharmacia in 2003 for $60 Billions, and Wyeth, for $68 billions in 2009. Sold for $16.6 billions its consumer-products division to Johnson & Johnson in 2006,
Big money is moving back and forth on minimum new medications of real benefits to the patients.
Pfizer should be looking for more Research and Development to add more drugs into its pipeline. The market place see minor amount of new drugs in general. Diversify its business model is also important.
The structure and laws in USA must be changed. The market structure should be geared into profitable R&D not marketing and Financial Engineering of the same back and forth. This is the hardest thing to do.
Just a thought.
No comments:
Post a Comment